Clearing Up Misperceptions About the Pain Standards

Published Online: Friday, November 1, 2013
Follow Pharmacy_Times:
In this podcast, Pat Adamski, director of the Joint Commission's Standards Interpretations Group, clears up common misperceptions about the organization's pain standards.

To listen to the podcast, click here.
Related Articles
Even short-term treatment with nonsteroidal anti-inflammatory drugs is associated with significant increases in bleeding and cardiovascular event risk in patients receiving antithrombotic therapy after a heart attack.
Most people hear “hospice” and think “cancer,” but many end-stage chronic obstructive pulmonary disease patients also receive hospice care when their caregivers can no longer provide the medical attention they need.
Dispensing higher opioid doses to chronic pain patients could trigger depression.
Narcotics are not recommended for managing chronic pain in children with inflammatory bowel disease, due to gastrointestinal side effects and potential dependence. Nevertheless, researchers have uncovered that long-term narcotic use is more than twice as prevalent in pediatric IBD patients compared with the general population.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$